Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 492

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care

Open access
Mynors-Wallis, L M, Gath, D H, Lloyd-Thomas, A R, Tomlinson, D·1995·BMJ

Abstract

Objective : To determine whether, in the treatment of major depression in primary care, a brief psychological treatment (problem solving) was (a) as effective as antidepressant drugs and more effective than placebo; (b) feasible in practice; and (c) acceptable to patients. Design : Randomised controlled trial of problem solving treatment, amitriptyline plus standard clinical management, and drug placebo plus standard clinical management. Each treatment was delivered in six sessions over 12 weeks. Setting : Primary care in Oxfordshire. Subjects : 91 patients in primary care who had major depression. Main outcome measures : Observer and self reported measures of severity of depression, self reported measure of social outcome, and observer measure of psychological symptoms at six and 12 weeks; self reported measure of patient satisfaction at 12 weeks. Numbers of patients recovered at six and 12 weeks. Results : At six and 12 weeks the difference in score on the Hamilton rating scale for depression between problem solving and placebo treatments was significant (5.3 (95% confidence interval 1.6 to 9.0) and 4.7 (0.4 to 9.0) respectively), but the difference between problem solving and amitriptyline was not significant (1.8 (−1.8 to 5.5) and 0.9 (−3.3 to 5.2) respectively). At 12 weeks 60% (18/30) of patients given problem solving treatment had recovered on the Hamilton scale compared with 52% (16/31) given amitriptyline and 27% (8/30) given placebo. Patients were satisfied with problem solving treatment; all patients who completed treatment (28/30) rated the treatment as helpful or very helpful. The six sessions of problem solving treatment totalled a mean therapy time of 3 1/2 hours. Conclusions : As a treatment for major depression in primary care, problem solving treatment is effective, feasible, and acceptable to patients. Key messages: Key messages Patient compliance with antidepressant treatment is often poor, so there is a need for a psychological treatment This study found that problem solving is an effective psychological treatment for major depression in primary care—as effective as amitriptyline and more effective than placebo Problem solving is a feasible treatment in primary care, being effective when given over six sessions by a general practitioner Problem solving treatment is acceptable to patients

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.310.6977.441

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 21

  1. Blacker, 1988, The prevalence and treatment of depression in general practice., Psychopharmacology, 95, S14, 10.1007/BF00172624 · DOI
  2. 10.1001/jama.1989.03430070062031 · DOI · Paper page
  3. Johnson, 1977, The severity of depression in patients treated in general practice., Journal of the Royal College of General Practitioners, 27, 419
  4. Porter, 1970, Depressive illness in a general practice. A demographic study and a controlled trial of imipramine., BMJ, i, 773, 10.1136/bmj.1.5699.773 · DOI
  5. Dunn, 1981, The natural history of depression in general practice: stochastic models., Psychol Med, 11, 755, 10.1017/S003329170004126X · DOI
  6. 1978, Lancet, ii, 1347
  7. Richels, 1970, Drug treatment in depressive illness., Diseases of the Nervous System, 31, 30
  8. Blashki, 1971, Controlled trial of amitriptyline in general practice., BMJ, i, 133, 10.1136/bmj.1.5741.133 · DOI
  9. 10.1016/0165-0327(88)90075-4 · DOI · Paper page
  10. Johnson, 1981, Depression: treatment compliance in general practice., Acta Psychiatr Scand, suppl, 447, 10.1111/j.1600-0447.1981.tb00751.x · DOI
  11. 10.1192/bjp.139.3.181 · DOI · Paper page
  12. 10.1192/bjp.144.4.400 · DOI
  13. Ross, 1985, An evaluation of the effectiveness of individual and group cognitive therapy in the treatment of depressed patients in an inner city health centre., Journal of the Royal College of General Practitioners, 35, 239
  14. Scott, 1992, Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks., BMJ, 304, 883, 10.1136/bmj.304.6831.883 · DOI
  15. Corney, 1981, Social work effectiveness in the management of depressed women: a clinical trial., Psychol Med, 11, 417, 10.1017/S0033291700052247 · DOI
  16. Hawton K Kirk J .Problem-solving. In: Hawton K Salkovskis P Kirk J Clark D ed.Cognitive behaviour therapy for psychiatric problems. Oxford: Oxford University Press,1989: 406–26. · DOI
  17. Spitzer, 1978, Research diagnostic criteria: rationale and reliability., Arch Gen Psychiatry, 36, 773, 10.1001/archpsyc.1978.01770300115013 · DOI
  18. 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
  19. Fawcett, 1987, Clinical management–imipramine/placebo administration manual., Psychopharmacol Bull, 23, 309
  20. Wing JK Hooper JE Sartorius N .The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press,1974.
  21. 10.1192/bjp.141.1.68 · DOI

Cited by

Metadata

Authors
Mynors-Wallis, L. M., Gath, D. H., Lloyd-Thomas, A. R., & Tomlinson, D.
Venue
BMJ
Publisher
BMJ
Published
1995-02-18
Volume
310
Issue
6977
Pages
441-445
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2015006744
Cited by
492
References
4
FWCI
24.32
Type
journal article
Language
en
Open access
green
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.